Skip to the page

Data / Form D filings / R3 Vascular Inc.

R3 Vascular Inc.: Form D filings

R3 Vascular Inc., a health care company in Mountain View, CA, filed 2 Form D notices with the SEC between 2020 and 2024. The latest, on September 12, 2024, reports $72.5 million sold of an offering with no set size to 34 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1145 Terra Bella Avenue, Mountain View, CA, 94043
Phone
(610) 585-6867
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1811520

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 12, 2024New noticeIndefinite$72,499,78134Apr 26, 2024sec.gov
May 18, 2020New notice$3,000,000$2,667,917$332,08323Aug 14, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Kamal M. RamzipoorExecutive Officer
Frederik M. GroenewegenDirector
John M. SpringerDirector
Michael M. HurleyDirector
David M. NeustaedterDirector
Christopher M. OwensExecutive Officer, Director
Amir M. AbolfathiDirector
Nathan M. HarringtonDirector

Other health care companies in California that filed recently

Every Form D from the week of Sep 9, 2024 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what R3 Vascular Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.